Neoadjuvant chemoradiation therapy for rectal cancer: current status and perspectives for the surgeon

Carregando...
Imagem de Miniatura
Citações na Scopus
Tipo de produção
article
Data de publicação
2017
Título da Revista
ISSN da Revista
Título do Volume
Editora
AME PUBL CO
Autores
JULIAO, Guilherme Pagin Sao
VAILATI, Bruna Borba
PEREZ, Rodrigo Oliva
Citação
ANNALS OF LAPAROSCOPIC AND ENDOSCOPIC SURGERY, v.2, article ID UNSP 87, 9p, 2017
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Modern management of rectal cancer has become increasingly complex over the last decades. The introduction of neoadjuvant chemoradiation to the treatment strategy of locally advanced and distal rectal cancers has added numerous variables that may ultimately affect final surgical or even non-surgical management. Specific chemoradiation regimens, intervals after neoadjuvant treatment completion and tools for the assessment of tumor response may all affect final surgical decision and should be interpreted with care. The present study attempts to provide a review of commonly used neoadjuvant chemoradiation regimens, specific intervals and final surgical or non-surgical management of rectal cancer in current clinical practice.
Palavras-chave
Rectal cancer, neoadjuvant therapy, total mesorectal excision (TME)
Referências
  1. [Anonymous], 1985, NEW ENGL J MED, V312, P1465
  2. Appelt AL, 2015, LANCET ONCOL, V16, P919, DOI 10.1016/S1470-2045(15)00120-5
  3. Biagi JJ, 2011, JAMA-J AM MED ASSOC, V305, P2335, DOI 10.1001/jama.2011.749
  4. Bipat S, 2004, RADIOLOGY, V232, P773, DOI 10.1148/radiol.2323031368
  5. Brown G, 2006, BRIT MED J, V333, P779, DOI 10.1136/bmj.38937.646400.55
  6. Bujko K, 2006, BRIT J SURG, V93, P1215, DOI 10.1002/bjs.5506
  7. de Campos-Lobato LF, 2011, J GASTROINTEST SURG, V15, P444, DOI 10.1007/s11605-010-1197-8
  8. Ellis CT, 2017, JAMA ONCOL, V3, P123, DOI 10.1001/jamaoncol.2016.3424
  9. Ellis CT, 2016, J CLIN ONCOL, V34, P1644, DOI 10.1200/JCO.2015.64.2066
  10. FISHER B, 1988, J NATL CANCER I, V80, P21, DOI 10.1093/jnci/80.1.21
  11. Folkesson J, 2005, J CLIN ONCOL, V23, P5644, DOI 10.1200/JCO.2005.08.144
  12. Francois Y, 1999, J CLIN ONCOL, V17, P2396, DOI 10.1200/JCO.1999.17.8.2396
  13. Garcia-Aguilar J, 2015, LANCET ONCOL, V16, P957, DOI 10.1016/S1470-2045(15)00004-2
  14. Gerard JP, 2012, CRIT REV ONCOL HEMAT, V81, P21, DOI 10.1016/j.critrevonc.2011.02.001
  15. Habr-Gama A, 1998, DIS COLON RECTUM, V41, P1087, DOI 10.1007/BF02239429
  16. Habr-Gama A, 2005, J GASTROINTEST SURG, V9, P90, DOI 10.1016/j.gassur.2004.10.010
  17. Habr-Gama A, 2004, ANN SURG, V240, P711, DOI 10.1097/01.sla.0000141194.27992.32
  18. Habr-Gama A, 2016, JAMA ONCOL
  19. Habr-Gama A, 2016, J CLIN ONCOL
  20. Habr-Gama A, 2008, INT J RADIAT ONCOL, V71, P1181, DOI 10.1016/j.ijrobp.2007.11.035
  21. Habr-Gama A, 2006, J GASTROINTEST SURG, V10, P1319, DOI 10.1016/j.gassur.2006.09.005
  22. Habr-Gama Angelita, 2014, Recent Results Cancer Res, V203, P203, DOI 10.1007/978-3-319-08060-4_14
  23. Habr-Gama A, 2013, DIS COLON RECTUM, V56, P1109, DOI 10.1097/DCR.0b013e3182a25c4e
  24. Habr-Gama A, 2010, DIS COLON RECTUM, V53, P1692, DOI 10.1007/DCR.0b013e3181f42b89
  25. Habr-Gama A, 2009, DIS COLON RECTUM, V52, P1927, DOI 10.1007/DCR.0b013e3181ba14ed
  26. HALL WH, 1990, JAMA-J AM MED ASSOC, V264, P1444
  27. HEALD RJ, 1982, BRIT J SURG, V69, P613, DOI 10.1002/bjs.1800691019
  28. Hendren SK, 2013, SURG CLIN N AM, V93, P1, DOI 10.1016/j.suc.2012.09.005
  29. Hida J, 1997, J AM COLL SURGEONS, V184, P584
  30. Kalady MF, 2009, ANN SURG, V250, P582, DOI 10.1097/SLA.0b013e3181b91e63
  31. Kapiteijn E, 2001, NEW ENGL J MED, V345, P638, DOI 10.1056/NEJMoa010580
  32. KROOK JE, 1991, NEW ENGL J MED, V324, P709, DOI 10.1056/NEJM199103143241101
  33. Lefevre JH, 2016, J CLIN ONCOL
  34. Maas M, 2010, LANCET ONCOL, V11, P835, DOI 10.1016/S1470-2045(10)70172-8
  35. Marijnen CAM, 2002, J CLIN ONCOL, V20, P817, DOI 10.1200/JCO.20.3.817
  36. Martling AL, 2000, LANCET, V356, P93, DOI 10.1016/S0140-6736(00)02469-7
  37. Massarweh NN, 2016, J SURG ONCOL, V114, P304, DOI 10.1002/jso.24267
  38. Memon S, 2015, COLORECTAL DIS, V17, P748, DOI 10.1111/codi.12976
  39. Minsky BD, 2012, J CLIN ONCOL, V30, P3777, DOI 10.1200/JCO.2012.45.0551
  40. Monson JRT, 2013, DIS COLON RECTUM, V56, P535, DOI 10.1097/DCR.0b013e31828cb66c
  41. Moore HG, 2004, DIS COLON RECTUM, V47, P279, DOI 10.1007/s10350-003-0062-1
  42. Nagtegaal ID, 2008, J CLIN ONCOL, V26, P303, DOI 10.1200/JCO.2007.12.7027
  43. Ngan SY, 2012, J CLIN ONCOL, V30, P3827, DOI 10.1200/JCO.2012.42.9597
  44. Nilsson PJ, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-279
  45. Pahlman L, 1997, NEW ENGL J MED, V336, P980
  46. Probst CP, 2015, J AM COLL SURGEONS, V221, P430, DOI 10.1016/j.jamcollsurg.2015.04.010
  47. QUIRKE P, 1986, LANCET, V2, P996
  48. Read TE, 2002, DIS COLON RECTUM, V45, P904, DOI 10.1097/01.DCR.0000019436.48544.D8
  49. Sauer R, 2004, NEW ENGL J MED, V351, P1731, DOI 10.1056/NEJMoa040694
  50. Sauer R, 2012, J CLIN ONCOL, V30, P1926, DOI 10.1200/JCO.2011.40.1836
  51. Schrag D, 2014, J CLIN ONCOL, V32, P513, DOI 10.1200/JCO.2013.51.7904
  52. SCOTT N, 1995, BRIT J SURG, V82, P1031, DOI 10.1002/bjs.1800820808
  53. Smith JD, 2012, ANN SURG, V256, P965, DOI 10.1097/SLA.0b013e3182759f1c
  54. Tulchinsky H, 2008, ANN SURG ONCOL, V15, P2661, DOI 10.1245/s10434-008-9892-3
  55. van Gijn W, 2011, LANCET ONCOL, V12, P575, DOI 10.1016/S1470-2045(11)70097-3
  56. WANEBO HJ, 1994, ANN SURG, V220, P586, DOI 10.1097/00000658-199410000-00017